Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).

MLA

Richards, Mark, et al. “Atrial Fibrillation Impairs the Diagnostic Performance of Cardiac Natriuretic Peptides in Dyspneic Patients: Results from the BACH Study (Biomarkers in ACute Heart Failure).” JACC. Heart Failure, vol. 1, no. 3, June 2013, pp. 192–99. EBSCOhost, https://doi.org/10.1016/j.jchf.2013.02.004.

APA

Richards, M., Di Somma, S., Mueller, C., Nowak, R., Peacock, W. F., Ponikowski, P., Mockel, M., Hogan, C., Wu, A. H. B., Clopton, P., Filippatos, G. S., Anand, I., Ng, L., Daniels, L. B., Neath, S.-X., Shah, K., Christenson, R., Hartmann, O., Anker, S. D., & Maisel, A. (2013). Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure). JACC. Heart Failure, 1(3), 192–199. https://doi.org/10.1016/j.jchf.2013.02.004

Chicago

Richards, Mark, Salvatore Di Somma, Christian Mueller, Richard Nowak, W Frank Peacock, Piotr Ponikowski, Martin Mockel, et al. 2013. “Atrial Fibrillation Impairs the Diagnostic Performance of Cardiac Natriuretic Peptides in Dyspneic Patients: Results from the BACH Study (Biomarkers in ACute Heart Failure).” JACC. Heart Failure 1 (3): 192–99. doi:10.1016/j.jchf.2013.02.004.